Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.it

PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune…

Over a decade of clinical data, experience and know-how with lead polyclonal Treg cell therapy PTG-007 in type-1 diabetes will accelerate CAR-Treg candidate developmentNew CAR-Treg cell therapy candidate is most advanced in growing engineered pipelineTwo new patents granted for engineered cell therapies, in U.S. and Japan Gdańsk, Poland – 26 September 2024– PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cellular therapies for a...

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

For media and investors only Indicated for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Leiden, the Netherlands, September 26, 2024:Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the United Kingdom (U.K.) Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Joenja® (leniolisib) for the treatment of...

ISUOG 2024 | Redefining Women's Health with SonoScape's New Fenix 80 Series

With its continued commitment to innovation and excellence, SonoScape remains at the forefront of advancing women's health through cutting-edge technology. The successful launch of the Fenix 80 Series at ISUOG 2024 underscores the company's dedication to empowering healthcare professionals with the tools they need to deliver better outcomes for patients worldwide. As SonoScape looks ahead, it is poised to further shape the future of medical imaging and provide transformative solutions that…

Personalised Energy Expenditure Data Enhances Weight Loss in Obesity: New Study…

Study Design: The assessor-blinded, randomised controlled trial involved 52 participants with class 3 obesity (BMI µ 42 Kg/m2), divided into an intervention group receiving personalised energy expenditure data and a standard care group. Over 24 weeks, the intervention group achieved greater weight loss and improved metabolic outcomes. Study Design : The assessor-blinded, randomised controlled trial involved 52 participants with class 3 obesity (BMI µ 42 Kg/m 2 ), divided into an intervention...

Global Prostate Cancer Diagnostics Market to Observe Stunning Growth at a CAGR…

Key Takeaways from the Prostate Cancer Diagnostics Market Report Key Takeaways from the Prostate Cancer Diagnostics Market Report To read more about the latest highlights related to the prostate cancer diagnostics market, get a snapshot of the key highlights entailed in the Global Prostate Cancer Diagnostics Market Report Prostate Cancer Diagnostics Overview Prostate cancer diagnostics involve a combination of tests and procedures aimed at detecting the presence of cancerous...

CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 |…

Key Takeaways from the CDK 7 Inhibitors Market Report Key Takeaways from the CDK 7 Inhibitors Market Report Discover which therapies are expected to grab the CDK 7 inhibitors market share @ CDK 7 Inhibitors Market Report CDK 7 Inhibitors Market Dynamics The CDK7 inhibitors market has gained significant attention in recent years, driven by thegrowing need for targeted cancer therapies. The market dynamics for CDK7 inhibitors are influenced by several factors, including...

Inventiva provides a corporate update and reports its unaudited 2024 first-half…

Recruitment in NATiV3 clinical trial progresses with over 85% of the targeted number of patients enrolled in the main cohort and a statistical powering of the study expected to be superior to 95% for both dosesevaluated in the trial.Baseline characteristics of patients randomized in the main cohort of NATiV3 remain consistent with the characteristics of patients enrolled in the completed Phase IIb, NATIVE, clinical trial.Blinded analyses of patients in NATiV3 suggest a positive...

SLEEVER® and CARBIOS globally launch world's first Home Compost biodegradable…

The SEELCAP® ONEGO innovation is the fruit of a long-term partnership between SLEEVER® and CARBIOS that combines their expertise to produce more environmentally friendly packaging securitySEELCAP® ONEGO will be presented on the SLEEVER (RF14, Hall Ravel) and CARBIOS (VA17, Hall Verrière) stands at LuxePack Monaco, to be held from 30 September to 2 October 2024 at the Grimaldi Forum Morangis and Clermont-Ferrand (France), Wednesday 25 September 2024 (18h00 CEST) :SLEEVER®, a French...

GUERBET : H1 2024 results.

H1 2024 results Very dynamic business activityH1 revenue: €419.2m, up 11.8% at CER 1 A trajectory driven by all activities and geographical areasSolid increase in profitabilityThe restated EBITDA margin 2was 15.4%, compared to 12.7% a year earlierOperating income almost tripled to €30.3mUpward revision of annual guidanceRevenue: expected growth of over 9% like-for-like and at CER (>8% previously)Profitability: restated EBITDA margin rate...

PHAXIAM Provides Business and Financial Update For the First Half of 2024

Continuous commitment to create a global leader in phage therapies to treat severe and resistant bacterial infections Ambitious development strategy on track with clear objectives set for the Prosthetic Joint Infections (PJI) strategic program Clinical readout expected before end of year 2024, including Updated Compassionate real life clinical data and PhagoDAIR pilot studyImminent Filing of Investigational New Drug Application (IND) in US and Clinical Trial Application (CTA) in...

UNION therapeutics announce results from the ADESOS Phase 2b study in atopic…

Mean percentage changes in EASI (Eczema Area and Severity Index) at Week 16 were: -55.1%, -52.2%, -61.4%, and -50.4%, in orismilast 20, 30, 40mg and placebo groups, respectively (p>0.05). Mean EASI at baseline was 23, the least severe reported in a Phase 2b/3 study in moderate to severe AD to date. This likely drove the high EASI placebo response also seen in other recent studies with more moderate patients. In the subgroup of patients with severe disease at baseline (EASI >21), active…

Boehringer Ingelheim expands cancer research at its Vienna site

Inauguration of Angelika Amon research building in Vienna Sustainable research building at a cost of EUR 60 million offers modern office and laboratory spaceOver the past five years, Boehringer's capital investments reached EUR 6.0 billionBoehringer Ingelheim is one of the world's leading research-oriented pharmaceutical companies. The clinical pipeline is constantly being further developed, and Boehringer Ingelheim expects new approvals also in oncology in the coming years.An...

Water Repellant for Textile Market Size to Grow USD 1153.4 Million by 2030 at a…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-8L14536/Global_Water_Repellant_for_Textile_Market Get Free Sample : https://reports.valuates.com/request/sample/QYRE-Auto-8L14536/Global_Water_Repellant_for_Textile_Market Major Trends: The Water Repellent for Textile Market has seen significant growth due to the rising demand for durable and high-performance textiles across various industries such as apparel, outdoor gear, and home furnishings. The market is...

Immune Checkpoint Inhibitors Market Surges to USD 168.76 Billion by 2030…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=857488 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=857488 Browse in-depth TOC onImmune Checkpoint Inhibitors Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Immune Checkpoint Inhibitors Market Overview Market Drivers Fueling Growth in the Immune Checkpoint Inhibitors Market Rising Incidence of Cancer The...

Baby Diapers Market is expected to generate a revenue of USD 96.23 Billion by…

As demand for baby diapers continues to grow globally, driven by increasing birth rates, rising consumer spending on hygiene products, and innovations in diaper technology, this report provides an essential roadmap for manufacturers, distributors, and key decision-makers in the baby care industry. With a focus on key market drivers, emerging trends, and regional dynamics, this report is set to be an indispensable resource for stakeholders looking to capitalize on untapped opportunities. As...

Coloplast A/S - Trading in Coloplast shares by board members, executives or…

Please see enclosed pdf. Attachment 25092024_trading_in_shares_N_P_Louis-Hansen_ApS

Sanner Group acquires Gilero to expand its global medical device offering

Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group's mission to offer a suite of world leading development and manufacturing services for its customers across the drug delivery and medical device sectors25 September 2024 - Sanner Group (“Sanner”), a leading global healthcare packaging and medical device CDMO has acquired Gilero LLC (“Gilero”), a world class medical device design, development, and contract manufacturer headquartered...

Rx-360 Announces Approval as a Pilot Center of Excellence for the APEC…

Economies are adversely impacted by the international movement of substandard and falsified medical products. As the medical products industry has become more globalized and specialized, APEC economies are faced with many challenges in keeping citizens healthy, while ensuring that access to legitimate products is not disrupted. To address this issue, the Roadmap for Global Medical Product Quality and Supply Chain Security project (Roadmap) was developed. The Roadmap was a multi-year effort…

Johns Hopkins Aramco Healthcare (JHAH) Partners with TruDoc Healthcare to…

Orion's collaboration partner Bayer submits application to U.S. FDA for third…

AB Science provides an update on the microtubule program AB8939 and in…

Press Release: Availability of the Q3 2024 Aide mémoire

Crossject announces its eligibility for France's PEA-PME investment scheme

Positive phase III results for Roche's Gazyva/Gazyvaro show superiority to…

PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune…

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

ISUOG 2024 | Redefining Women's Health with SonoScape's New Fenix 80 Series

Personalised Energy Expenditure Data Enhances Weight Loss in Obesity: New Study…

Global Prostate Cancer Diagnostics Market to Observe Stunning Growth at a CAGR…

CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 |…

Inventiva provides a corporate update and reports its unaudited 2024 first-half…

SLEEVER® and CARBIOS globally launch world's first Home Compost biodegradable…

GUERBET : H1 2024 results.

PHAXIAM Provides Business and Financial Update For the First Half of 2024

UNION therapeutics announce results from the ADESOS Phase 2b study in atopic…

Boehringer Ingelheim expands cancer research at its Vienna site

Water Repellant for Textile Market Size to Grow USD 1153.4 Million by 2030 at a…

Immune Checkpoint Inhibitors Market Surges to USD 168.76 Billion by 2030…

Baby Diapers Market is expected to generate a revenue of USD 96.23 Billion by…

Coloplast A/S - Trading in Coloplast shares by board members, executives or…

Sanner Group acquires Gilero to expand its global medical device offering

Rx-360 Announces Approval as a Pilot Center of Excellence for the APEC…